Salmeterol/Fluticasone Neutec 50 mikrog / 100 mikrog 노르웨이 - 노르웨이어 - Statens legemiddelverk

salmeterol/fluticasone neutec 50 mikrog / 100 mikrog

neutec inhaler ireland limited - salmeterolxinafoat / flutikasonpropionat - inhalasjonspulver, dosedispensert - 50 mikrog / 100 mikrog

Salmeterol/Fluticasone Neutec 50 mikrog / 250 mikrog 노르웨이 - 노르웨이어 - Statens legemiddelverk

salmeterol/fluticasone neutec 50 mikrog / 250 mikrog

neutec inhaler ireland limited - salmeterolxinafoat / flutikasonpropionat - inhalasjonspulver, dosedispensert - 50 mikrog / 250 mikrog

Solifenacin Sandoz 10 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

solifenacin sandoz 10 mg

sandoz - københavn - solifenacinsuksinat - tablett, filmdrasjert - 10 mg

Solifenacin Sandoz 5 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

solifenacin sandoz 5 mg

sandoz - københavn - solifenacinsuksinat - tablett, filmdrasjert - 5 mg

Lilinorm 5 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

lilinorm 5 mg

ace pharmaceuticals bv - hydrokortison - tablett, filmdrasjert - 5 mg

Lilinorm 5 mg / 10 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

lilinorm 5 mg / 10 mg

ace pharmaceuticals bv - hydrokortison - tablett, filmdrasjert - 5 mg / 10 mg

Lilinorm 1 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

lilinorm 1 mg

ace pharmaceuticals bv - hydrokortison - tablett, filmdrasjert - 1 mg

Onglyza 유럽 연합 - 노르웨이어 - EMA (European Medicines Agency)

onglyza

astrazeneca ab - saxagliptin - diabetes mellitus, type 2 - legemidler som brukes i diabetes - add-on combination therapyonglyza is indicated in adult patients aged 18 years and older with type-2 diabetes mellitus to improve glycaemic control:as monotherapy:in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance;as dual oral therapy:in combination with metformin, when metformin alone, with diet and exercise, does not provide adequate glycaemic control;in combination with a sulphonylurea, when the sulphonylurea alone, with diet and exercise, does not provide adequate glycaemic control in patients for whom use of metformin is considered inappropriate;in combination with a thiazolidinedione, when the thiazolidinedione alone with diet and exercise, does not provide adequate glycaemic control in patients for whom use of a thiazolidinedione is considered appropriate;as triple oral therapy:in combination with metformin plus a sulphonylurea when this regimen alone, with diet and exercise, does not provide adequate glycaemic control;as combination therapy with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.

Entocort 2 mg/100 ml 노르웨이 - 노르웨이어 - Statens legemiddelverk

entocort 2 mg/100 ml

tillotts pharma gmbh - budesonid - tablett og væske til rektalvæske, suspensjon - 2 mg/100 ml

Urizia 6 mg / 0.4 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

urizia 6 mg / 0.4 mg

astellas pharma a/s - solifenacinsuksinat / tamsulosinhydroklorid - tablett med modifisert frisetting - 6 mg / 0.4 mg